RECALL Contour PLUS Blood Glucose Test Strips

Summary (Newest Update)

Background The Department of Veterans Affairs, specifically VISN 17, is issuing a sole-source award to Ascensia Diabetes Care US Inc. for the urgent procurement of CONTOUR PLUS Blue Blood Glucose Test Strips and associated replacement system kits. This action is necessitated by an FDA-classified Class I Recall affecting glucose monitoring supplies currently in clinical circulation, which poses significant patient safety risks. Ascensia Diabetes Care US Inc. is the original equipment manufacturer (OEM) and the only source capable of supplying the required FDA-cleared recall replacement materials within the necessary time-frame to mitigate risk. Work Details The required supplies include: - CONTOUR PLUS Blood Glucose Test Strips, 50-count (Item #00193) - CONTOUR PLUS System Kits, including the meter and required accessories for full recall replacement. These items must be directly shipped to affected veterans to ensure timely recall compliance and uninterrupted access to safe glucose monitoring supplies. The procurement will be executed under a Firm-Fixed Price arrangement with an estimated value of $714,840.00. Period of Performance June 3, 2026 through July 29, 2027 Place of Performance Direct shipment to affected veterans' locations as determined by VISN 17. Bidder Requirements Ascensia Diabetes Care US Inc. is the OEM and sole manufacturer of the CONTOUR PLUS test strips and system kits required for replacement under the FDA Class I Recall. No alternative products or sources can meet the technical, compatibility, or recall compliance requirements within the urgent time-frame. Ascensia does not authorize third-party production, and no other vendor can supply FDA-cleared, recall-compliant items that meet the required specifications.